Autophagy as a therapeutic target in pancreatic cancer

por Piffoux, Max, Eriau, Erwan, Cassier, Philippe A.
Publicado 2020

Targeting apoptosis in acute myeloid leukaemia

por Cassier, Philippe A, Castets, Marie, Belhabri, Amine, Vey, Norbert
Publicado 2017

Trabectedin and its potential in the treatment of soft tissue sarcoma

por Cassier, Philippe A, Dufresne, Armelle, Blay, Jean-Yves, Fayette, Jérôme
Publicado 2008

Tocilizumab for the treatment of paraneoplastic inflammatory syndrome associated with angiomatoid fibrous histiocytoma

por Eberst, Lauriane, Cassier, Philippe A, Brahmi, Mehdi, Tirode, Franck, Blay, Jean-Yves
Publicado 2020

Outcome of patients with advanced solitary fibrous tumors: the Centre Léon Bérard experience

por Levard, Alice, Derbel, Olfa, Méeus, Pierre, Ranchère, Dominique, Ray-Coquard, Isabelle, Blay, Jean-Yves, Cassier, Philippe A
Publicado 2013

New developments in treatment of ovarian carcinoma: focus on trabectedin

por Cassier, Philippe A, Duret, Aude, Trédan, Olivier, Carrabin, Nicolas, Méeus, Pierre, Treilleux, Isabelle, Guastalla, Jean-Paul, Ray-Coquard, Isabelle
Publicado 2010

Combining chemotherapeutic agents and netrin-1 interference potentiates cancer cell death

por Paradisi, Andrea, Creveaux, Marion, Gibert, Benjamin, Devailly, Guillaume, Redoulez, Emeline, Neves, David, Cleyssac, Elsa, Treilleux, Isabelle, Klein, Christian, Niederfellner, Gerhard, Cassier, Philippe A, Bernet, Agnès, Mehlen, Patrick
Publicado 2013

Neoadjuvant imatinib in patients with locally advanced non metastatic GIST in the prospective BFR14 trial

por Blesius, Aurore, Cassier, Philippe A, Bertucci, François, Fayette, Jerome, Ray-Coquard, Isabelle, Bui, Binh, Adenis, Antoine, Rios, Maria, Cupissol, Didier, Pérol, David, Blay, Jean-Yves, Le Cesne, Axel
Publicado 2011

Antiangiogenic effects in patients with progressive desmoplastic small round cell tumor: data from the French national registry dedicated to the use of off-labeled targeted therapy...

por Bétrian, Sarah, Bergeron, Christophe, Blay, Jean-Yves, Bompas, Emmanuelle, Cassier, Philippe A., Chevallier, Laure, Fayette, Jérome, Girodet, Magali, Guillemet, Cécile, Le Cesne, Axel, Marec-Berard, Perrine, Ray-Coquard, Isabelle, Chevreau, Christine
Publicado 2017

Prognostic value of the expression of C-Chemokine Receptor 6 and 7 and their ligands in non-metastatic breast cancer

por Cassier, Philippe A, Treilleux, Isabelle, Bachelot, Thomas, Ray-Coquard, Isabelle, Bendriss-Vermare, Nathalie, Ménétrier-Caux, Christine, Trédan, Olivier, Goddard-Léon, Sophie, Pin, Jean-Jacques, Mignotte, Hervé, Bathélémy-Dubois, Clarisse, Caux, Christophe, Lebecque, Serge, Blay, Jean-Yves
Publicado 2011

Pharmacokinetic–pharmacodynamic guided optimisation of dose and schedule of CGM097, an HDM2 inhibitor, in preclinical and clinical studies

por Bauer, Sebastian, Demetri, George D., Halilovic, Ensar, Dummer, Reinhard, Meille, Christophe, Tan, Daniel S. W., Guerreiro, Nelson, Jullion, Astrid, Ferretti, Stephane, Jeay, Sebastien, Van Bree, Laurence, Hourcade-Potelleret, Florence, Wuerthner, Jens U., Fabre, Claire, Cassier, Philippe A.
Publicado 2021

Pembrolizumab in Patients With Microsatellite Instability–High Advanced Endometrial Cancer: Results From the KEYNOTE-158 Study

por O'Malley, David M., Bariani, Giovanni Mendonca, Cassier, Philippe A., Marabelle, Aurelien, Hansen, Aaron R., De Jesus Acosta, Ana, Miller, Wilson H., Safra, Tamar, Italiano, Antoine, Mileshkin, Linda, Xu, Lei, Jin, Fan, Norwood, Kevin, Maio, Michele
Publicado 2022

Phase 1 study of the MDM2 inhibitor AMG 232 in patients with advanced P53 wild-type solid tumors or multiple myeloma

por Gluck, W. Larry, Gounder, Mrinal M., Frank, Richard, Eskens, Ferry, Blay, Jean Yves, Cassier, Philippe A., Soria, Jean-Charles, Chawla, Sant, de Weger, Vincent, Wagner, Andrew J., Siegel, David, De Vos, Filip, Rasmussen, Erik, Henary, Haby A.
Publicado 2019

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors

por Molife, L Rhoda, Yan, Li, Vitfell-Rasmussen, Joanna, Zernhelt, Adriane M, Sullivan, Daniel M, Cassier, Philippe A, Chen, Eric, Biondo, Andrea, Tetteh, Ernestina, Siu, Lillian L, Patnaik, Amita, Papadopoulos, Kyriakos P, de Bono, Johann S, Tolcher, Anthony W, Minton, Susan
Publicado 2014

Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial

por Subbiah, Vivek, Cassier, Philippe A., Siena, Salvatore, Garralda, Elena, Paz-Ares, Luis, Garrido, Pilar, Nadal, Ernest, Vuky, Jacqueline, Lopes, Gilberto, Kalemkerian, Gregory P., Bowles, Daniel W., Seetharam, Mahesh, Chang, Jianhua, Zhang, Hui, Green, Jennifer, Zalutskaya, Alena, Schuler, Martin, Fan, Yun, Curigliano, Giuseppe
Publicado 2022

Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial

por Jones, Robin L., Serrano, César, von Mehren, Margaret, George, Suzanne, Heinrich, Michael C., Kang, Yoon-Koo, Schöffski, Patrick, Cassier, Philippe A., Mir, Olivier, Chawla, Sant P., Eskens, Ferry A.L.M., Rutkowski, Piotr, Tap, William D., Zhou, Teresa, Roche, Maria, Bauer, Sebastian
Publicado 2021

Multi-Purpose Utility of Circulating Plasma DNA Testing in Patients with Advanced Cancers

por Perkins, Geraldine, Yap, Timothy A., Pope, Lorna, Cassidy, Amy M., Dukes, Juliet P., Riisnaes, Ruth, Massard, Christophe, Cassier, Philippe A., Miranda, Susana, Clark, Jeremy, Denholm, Katie A., Thway, Khin, Gonzalez De Castro, David, Attard, Gerhardt, Molife, L. Rhoda, Kaye, Stan B., Banerji, Udai, de Bono, Johann S.
Publicado 2012

Therapeutic targeting of macrophages enhances chemotherapy efficacy by unleashing type I interferon response

por Salvagno, Camilla, Ciampricotti, Metamia, Tuit, Sander, Hau, Cheei-Sing, van Weverwijk, Antoinette, Coffelt, Seth B., Kersten, Kelly, Vrijland, Kim, Kos, Kevin, Ulas, Thomas, Song, Ji-Ying, Ooi, Chia-Huey, Rüttinger, Dominik, Cassier, Philippe A., Jonkers, Jos, Schultze, Joachim L., Ries, Carola H., de Visser, Karin E.
Publicado 2019

Precision medicine for patients with gastro-oesophageal cancer: A subset analysis of the ProfiLER program

por Cassier, Philippe A., Peyramaure, Clémentine, Attignon, Valery, Eberst, Lauriane, Pacaud, Camille, Boyault, Sandrine, Desseigne, Françoise, Sarabi, Mathieu, Guibert, Pierre, Rochefort, Pauline, Marques, Nathalie, Rivoire, Michel, Dupré, Aurélien, Peyrat, Patrice, Terret, Catherine, Ray-Coquard, Isabelle, Coutzac, Clélia, Pérol, David, Blay, Jean-Yves, Trédan, Olivier, de la Fouchardière, Christelle
Publicado 2021

First-in-human phase 1 study of budigalimab, an anti-PD-1 inhibitor, in patients with non-small cell lung cancer and head and neck squamous cell carcinoma

por Italiano, Antoine, Cassier, Philippe A., Lin, Chia-Chi, Alanko, Tuomo, Peltola, Katriina J., Gazzah, Anas, Shiah, Her-Shyong, Calvo, Emiliano, Cervantes, Andrés, Roda, Desamparados, Tosi, Diego, Gao, Bo, Millward, Michael, Warburton, Lydia, Tanner, Minna, Englert, Stefan, Lambert, Stacie, Parikh, Apurvasena, Afar, Daniel E., Vosganian, Gregory, Moreno, Victor
Publicado 2021